US launches Germany pharma pricing probe, raising threat of new tariffs

AI Summary

The United States has launched an investigation into German pharmaceutical pricing policies, raising the prospect of new tariffs. The probe will examine whether Germany's pricing unfairly disadvantages US commerce under Section 301 trade rules.

Germany came under fresh US trade scrutiny on Thursday as the United States launched an investigation into the country's pharmaceutical pricing policies, a move that could pave the way for new tariffs. Washington said it would examine whether Germany's pricing practices unfairly underpay for innovative medicines and burden US commerce under Section 301 trade authorities.